StratifAI
Precision Oncology
1 open rolePrecision OncologyBerlin, Germany11-50$14M raisedEst. 2022
Picus Capital
Alven
Heliad
Rubin Ritter
Lars Langusch
Arve Capital
About StratifAI
- StratifAI is a precision oncology company developing the next generation of AI-based biomarkers to advance cancer diagnostics.
- It leverages its multimodal AI discovery platform, Polaris™, to identify prognostic and predictive biomarkers from clinical data and assess metastatic risk.
StratifAI is listed on Rocketlist with 1 active role. The company is categorized as Precision Oncology in HealthTech. StratifAI is at Seed stage, with a B2B business model, headquartered in Berlin, Germany. StratifAI was founded in 2022. StratifAI has raised $14M. Active roles are refreshed daily from public hiring sources.